Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

Original Research

Douglas C. A. Taylor, MBA
Jessica L. Abel, MPH
Tim Bancroft, PhD
Paul Buzinec, MS
Alyssa Goolsby Hunter, MA
Robyn T. Carson, MPH
Carolyn Martin, MSW
As expected, pharmacy costs increased with the introduction of this new treatment in a market dominated by over-the-counter and generic treatments. On the other hand, outpatient GI-related and irritable bowel disease health care resource use and costs substantially decreased among commercial and Medicare patients following linaclotide treatment initiation.
Holly Miller, MD
Lucy Johns, MPH
The document “Feature and Function Recommendations To Optimize Clinician Usability of Direct Interoperability To Enhance Patient Care” offers recommendations from the clinician point of view. Widespread adoption of even a few of these recommendations by designers and vendors would greatly enhance care.
Patrick Kearns, MD, FACP
Studies comparing team care of diabetes with traditional care should be redesigned, say researchers. “In order for redesign studies to support generalization of their findings, methodology should include a randomized, controlled study design with intention-to-treat analysis,” the study states.
Ray D. Page, DO, PhD
A. Christine Argento, MD
David B. Nash, MD, MBA
Alexandria Skoufalos, EdD
Eric S. Schaefer, MD
Accurate prognostic estimates can predict and document expected response to treatment, avoid ineffective and costly overtreatment, and facilitate meaningful discussions with lung cancer patients about the timing of best supportive care and hospice care when appropriate, thereby improving cancer care planning and quality scores.
Michael P. Johnson, MS
Jonathan C. Johnson, MS
Nicole M. Engel-Nitz, PhD
Qayyim Said, PhD
Judith Prestifilippo, MD
Tanjala T. Gipson, MD
James Wheless, MD
Tuberous sclerosis complex (TSC) is a rare genetic disorder affecting the brain and other vital organs with varying symptoms and severity among patients. This study developed and validated a risk model to identify patients with TSC using large databases of medical and pharmacy claims.
Brooke Roeper, MSPH, MS
Eric Beck, DO, MPH, FACEP
Daniel Castillo, MD, MBA
J. Brent Myers, MD, MPH
Brandy Sparkman, RN, BSN
Jonathan Cox, MHS
Scott Bourn, PhD, RN, EMT-P
One in five elderly patients returns to the hospital within 30 days of leaving. These rehospitalizations are a common and costly occurrence. A program developed to address problems in post-acute transitional care seems to be effective in reducing 30-day readmission rates for some Medicare fee-for-service beneficiaries.
Jennifer Jones, MD, FRCPC
Mark Borgaonkar, MD, MSc, FRCPC
Jesse Siffledeen, MD, MSc, FRCPC
Ryan O’Reilly, BSc
Dana Anger, MSc
Dorota Dajnowiec, PhD
Martin Williamson, PhD
Peter Dyrda, BSc, MBA
Patients have a positive experience with IV infusions of infliximab within the BioAdvance PSP. The personnel and services associated with the program appear to be helpful to, and valued by, patients. The services enhance the overall treatment experience and potentially improve adherence and long-term health outcomes.
Sze-jung Wu, PhD
Qinli Ma, PhD
Patricia Martin, RN, BSN
Andrea DeVries, PhD
Value-based centers of excellence programs offer an advance over programs that focus only on cost or quality alone in the ability to identify facilities with lower costs and equal or better quality outcomes. Value designation offers patients transparency for selecting care providers.